Initiation of phase 1 portion of the trial planned in 2H 2026 -Phase 2 portion of the trial will initiate development of the elraglusib tablet in specific indications, including refractory melanoma ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Sai Parenteral Limited and Hella Infra Market have received final approval for their IPOs from Sebi. Sai Parenteral's ...

The consultation about the future of one of England’s oldest parishes, Brindle St Joseph, has concluded with more than 40 ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

PHARMACISTS are being forced to ration supplies of a life-saving painkiller amid a “dangerous” drug shortage, health ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...

This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.